Protara Therapeutics, Inc.
TARA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001359931
In the last 90 days, Protara Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 119 institutions reported holding it in 13F filings for Q2 2026, worth $176.0M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Protara Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- +4 vs. Q1 2024
- Shares held
- 10.4M
- +5.88M (+128.6%) vs. Q1 2024
- Total value
- $22.2M
- +$3.89M (+21.2%) vs. Q1 2024
- New holders
- 11
- 14 more added
- Sold out
- 7
- 7 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TARA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 119 | $176.0M |
| Q1 2026 | 114 | $237.4M |
| Q4 2025 | 105 | $212.3M |
| Q3 2025 | 81 | $114.0M |
| Q2 2025 | 76 | $90.1M |
| Q1 2025 | 59 | $123.8M |
| Q4 2024 | 60 | $156.6M |
| Q3 2024 | 35 | $19.1M |
| Q2 2024 | 38 | $22.2M |
| Q1 2024 | 34 | $18.3M |
| Q4 2023 | 30 | $8.17M |
| Q3 2023 | 31 | $8.55M |
| Q2 2023 | 29 | $12.3M |
| Q1 2023 | 29 | $16.9M |
| Q4 2022 | 30 | $14.7M |
| Q3 2022 | 31 | $16.7M |
| Q2 2022 | 33 | $18.4M |
| Q1 2022 | 35 | $33.2M |
| Q4 2021 | 38 | $46.5M |
| Q3 2021 | 36 | $43.7M |
| Q2 2021 | 40 | $69.3M |
| Q1 2021 | 50 | $134.0M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Protara Therapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Qube Research & Technologies Ltd | 2 | $4 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 100 | $208 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 149 | $310 | 0.00% | +149 | New |
| Wells Fargo & Company | 500 | $1.04K | 0.00% | −70−12.3% | Reduced |
| Group One Trading, L.P. | 2,550 | $5.30K | 0.00% | +2,550 | New |
| Tower Research Capital LLC (TRC) | 4,019 | $8.36K | 0.00% | +1,439+55.8% | Added |
| Royal Bank of Canada | 6,302 | $13.0K | 0.00% | +2,316+58.1% | Added |
| Susquehanna International Group, LLP | 10,036 | $20.9K | 0.00% | −1,149−10.3% | Reduced |
| Jane Street Group, LLC | 12,850 | $26.7K | 0.00% | +12,850 | New |
| Bank of New York Mellon Corp | 17,907 | $37.2K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 19,428 | $40.0K | 0.00% | +19,428 | New |
| Truist Financial Corp | 20,000 | $41.6K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 20,191 | $42.0K | 0.00% | −2,456−10.8% | Reduced |
| Bridgeway Capital Management, LLC | 24,200 | $50.3K | 0.00% | −34,800−59.0% | Reduced |
| State Street Corp | 26,600 | $55.3K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 28,976 | $60.3K | 0.00% | +11,385+64.7% | Added |
| CIBC World Markets Inc. | 37,000 | $77.0K | 0.00% | +37,000 | New |
| LPL Financial LLC | 44,000 | $91.5K | 0.00% | +16,000+57.1% | Added |
| Marshall Wace, LLP | 77,351 | $160.9K | 0.00% | +77,351 | New |
| Two Sigma Advisers, LP | 80,518 | $167.5K | 0.00% | +53,500+198.0% | Added |
| Woodline Partners LP | 100,001 | $208.0K | 0.00% | +100,001 | New |
| Privium Fund Management (UK) Ltd | 114,708 | $232.9K | 0.09% | −5,022−4.2% | Reduced |
| BlackRock Inc. | 115,273 | $239.8K | 0.00% | +84,409+273.5% | Added |
| Oppenheimer & Co Inc | 127,181 | $264.5K | 0.00% | +117,181+1,171.8% | Added |
| Geode Capital Management, LLC | 140,526 | $292.3K | 0.00% | +57,619+69.5% | Added |
| Renaissance Technologies LLC | 150,400 | $312.8K | 0.00% | +65,800+77.8% | Added |
| Two Sigma Investments, LP | 155,773 | $324.0K | 0.00% | +136,025+688.8% | Added |
| Ikarian Capital, LLC | 180,712 | $375.9K | 0.12% | −21,989−10.8% | Reduced |
| CVI Holdings, LLC | 302,746 | $629.7K | 0.54% | +302,746 | New |
| Vanguard Group Inc | 427,612 | $889.4K | 0.00% | 00.0% | Unchanged |
| Velan Capital Investment Management LP | 480,000 | $998.4K | 0.57% | +480,000 | New |
| Armistice Capital, LLC | 520,000 | $1.08M | 0.03% | +520,000 | New |
| Baker Bros. Advisors LP | 536,832 | $1.12M | 0.01% | +337,161+168.9% | Added |
| Citadel Advisors LLC | 665,372 | $1.38M | 0.00% | +639,424+2,464.3% | Added |
| Boxer Capital, LLC | 811,627 | $1.69M | 0.09% | +602,400+287.9% | Added |
| StemPoint Capital LP | 984,113 | $2.05M | 0.60% | +815,671+484.2% | Added |
| Ra Capital Management, L.P. | 1,900,000 | $3.95M | 0.05% | +1,900,000 | New |
| Opaleye Management Inc. | 2,304,262 | $5.30M | 1.21% | −388,332−14.4% | Reduced |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −17,850−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −17,393−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −12,126−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −6,314−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −3,725−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −22−100.0% | Sold out |